GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » Purchase Of Investment

Renhe Pharmacy Co (SZSE:000650) Purchase Of Investment : ¥-10,487 Mil (TTM As of Mar. 2025)


View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co Purchase Of Investment?

Renhe Pharmacy Co's purchase of investment for the three months ended in Mar. 2025 was ¥-4,121 Mil. It means Renhe Pharmacy Co spent ¥4,121 Mil on purchasing investments. Renhe Pharmacy Co's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-10,487 Mil.

Compared with last quarter (¥-2,935 Mil in Dec. 2024 ), Renhe Pharmacy Co spent more money on purchasing investments in Mar. 2025 (¥-4,121 Mil).


Renhe Pharmacy Co Purchase Of Investment Historical Data

The historical data trend for Renhe Pharmacy Co's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co Purchase Of Investment Chart

Renhe Pharmacy Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11,925.04 -10,846.79 -8,033.04 -6,233.56 -9,836.82

Renhe Pharmacy Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,470.62 -1,605.56 -1,825.83 -2,934.81 -4,120.63

Renhe Pharmacy Co Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-10,487 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renhe Pharmacy Co Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Renhe Pharmacy Co's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Renhe Pharmacy Co Business Description

Traded in Other Exchanges
N/A
Address
No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038
Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.
Executives
Yang Xiao Director
Kang Zhi Hua Supervisors
Mei Qiang Directors, executives
Yang Wen Long Director

Renhe Pharmacy Co Headlines

No Headlines